| P50 | author | Catherine M Roe | Q105996775 |
| P2093 | author name string | Patrick C Harper | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| | The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 |
| | The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers | Q31081008 |
| | Treatment of Alzheimer's disease | Q33779004 |
| | The Colorado thyroid disease prevalence study | Q33891706 |
| | Mild cognitive impairment represents early-stage Alzheimer disease | Q33938635 |
| | Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). | Q34113424 |
| | Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein | Q34340647 |
| | Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study | Q35138401 |
| | Estrogen use and early onset Alzheimer's disease: a population-based study | Q35454336 |
| | Tools of the epidemiologist | Q36569227 |
| | Vascular cognitive deterioration and stroke | Q36986449 |
| | Thyroid function and the risk of Alzheimer disease: the Framingham Study | Q37223038 |
| | Subclinical hypothyroidism in a biethnic, urban community | Q39510306 |
| | Thyroid hormone regulates endogenous amyloid-beta precursor protein gene expression and processing in both in vitro and in vivo models | Q40188127 |
| | Frequency, distribution, and risk factors for Alzheimer's disease | Q40721278 |
| | Regulation of microglial development: a novel role for thyroid hormone. | Q43540463 |
| | New insights into the role of thyroid hormone in the CNS: the microglial track | Q43861789 |
| | Hypothyroidism and cognition: preliminary evidence for a specific defect in memory | Q44108189 |
| | Overshooting the mark: subclinical hyperthyroidism secondary to excess thyroid hormone treatment may be more prevalent than we realise. | Q46078999 |
| | Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. | Q46458206 |
| | Clinical outcomes of possible versus probable Alzheimer's disease | Q47636799 |
| | Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells | Q48024383 |
| | Alcohol related dementia: proposed clinical criteria | Q48437960 |
| | Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype | Q48499517 |
| | Quantitative neurohistological features of frontotemporal degeneration | Q49140415 |
| | Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. | Q50999429 |
| | Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. | Q52011595 |
| | The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota. | Q53183215 |
| | Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. | Q53254556 |
| | The prevalence and malignancy of Alzheimer disease: a major killer. | Q53297615 |
| | Clinical Dementia Rating (CDR). | Q53304372 |
| | Risk factors for Alzheimer's disease in Russia: a case-control study. | Q53381225 |
| | Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study | Q57782109 |
| | The pathology and nosology of primary progressive aphasia | Q72829550 |
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 63-69 | |
| P577 | publication date | 2009-08-07 | |
| P1433 | published in | Journal of Geriatric Psychiatry and Neurology | Q6295256 |
| P1476 | title | Thyroid medication use and subsequent development of dementia of the Alzheimer type | |
| P478 | volume | 23 | |